See more : Nordic Paper Holding AB (publ) (NPAPER.ST) Income Statement Analysis – Financial Results
Complete financial analysis of Medical Developments International Limited (MVP.AX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Medical Developments International Limited, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- BioGaia AB (publ) (BIOGY) Income Statement Analysis – Financial Results
- LS Invest AG (IFA.DE) Income Statement Analysis – Financial Results
- Guideline Geo AB (publ) (GGEO.ST) Income Statement Analysis – Financial Results
- Creative Realities, Inc. (CREX) Income Statement Analysis – Financial Results
- Novem Group S.A. (NVM.DE) Income Statement Analysis – Financial Results
Medical Developments International Limited (MVP.AX)
About Medical Developments International Limited
Medical Developments International Limited manufactures and distributes emergency medical solutions in Australia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It offers respiratory devices for sufferers of asthma and chronic obstructive pulmonary disease; Penthrox, a trauma and emergency pain relief product; and medical devices, such as CPR face shield key rings, CPR masks, finger pulse oximeters, flow meter regulators, MDI tourniquets, manually triggered ventilators, OXI port carry and hand bags, oxygen resuscitation kits, oxygen therapy masks, and resuscitators. The company was incorporated in 2003 and is headquartered in Scoresby, Australia.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 33.15M | 32.34M | 21.94M | 25.27M | 22.54M | 20.88M | 17.46M | 18.35M | 15.47M | 11.61M | 9.37M | 11.73M | 11.31M | 10.21M | 8.30M | 8.73M | 9.22M | 7.40M | 6.61M | 5.40M | 3.05M | 5.48M |
| Cost of Revenue | 8.78M | 34.85M | 25.00M | 8.60M | 8.80M | 6.69M | 5.10M | 5.76M | 4.26M | 3.55M | 3.05M | 3.40M | 3.47M | 3.67M | 2.99M | 3.03M | 3.50M | 2.51M | 2.24M | 1.93M | 1.04M | 0.00 |
| Gross Profit | 24.37M | -2.52M | -3.06M | 16.67M | 13.74M | 14.18M | 12.36M | 12.58M | 11.21M | 8.05M | 6.32M | 8.33M | 7.85M | 6.54M | 5.30M | 5.70M | 5.72M | 4.89M | 4.37M | 3.48M | 2.01M | 5.48M |
| Gross Profit Ratio | 73.50% | -7.78% | -13.95% | 65.98% | 60.96% | 67.94% | 70.81% | 68.58% | 72.46% | 69.38% | 67.45% | 71.00% | 69.35% | 64.05% | 63.93% | 65.27% | 62.09% | 66.10% | 66.16% | 64.36% | 65.88% | 100.00% |
| Research & Development | 0.00 | 236.00K | 220.00K | 536.00K | 396.00K | 510.00K | 359.00K | 199.00K | 164.00K | 200.00K | 99.00K | 41.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 32.55M | 32.58M | 22.21M | 15.23M | 4.32M | 4.14M | 3.99M | 3.70M | 3.56M | 2.03M | 1.74M | 1.37M | 1.69M | 1.69M | 1.66M | 2.12M | 1.51M | 1.24M | 1.29M | 1.53M | 800.00K | 0.00 |
| Selling & Marketing | 2.82M | 3.83M | 2.60M | 1.31M | 5.38M | 4.27M | 4.44M | 3.70M | 2.54M | 1.75M | 2.08M | 2.12M | 1.62M | 1.51M | 1.05M | 1.01M | 1.51M | 1.03M | 979.00K | 672.00K | 224.00K | 0.00 |
| SG&A | 35.37M | 17.76M | 12.64M | 21.38M | 11.47M | 9.67M | 9.33M | 8.01M | 6.64M | 4.18M | 4.21M | 3.82M | 3.31M | 3.20M | 2.71M | 3.13M | 3.02M | 2.27M | 2.27M | 2.20M | 1.02M | 0.00 |
| Other Expenses | -11.00M | 19.10M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.90M | 1.10M | 111.00K | 25.00K | 41.00K | 181.00K | 123.00K | 50.00K | 100.00K | 50.00K | 71.00K | 7.00K | 7.00K | 4.00K | -3.13M |
| Operating Expenses | 24.37M | 17.76M | 12.64M | 21.91M | 11.87M | 13.01M | 11.92M | 10.12M | 8.91M | 5.80M | 5.55M | 5.18M | 4.66M | 4.65M | 4.44M | 4.98M | 4.81M | 3.44M | 3.31M | 3.59M | 1.57M | 347.00K |
| Cost & Expenses | 50.02M | 52.61M | 37.64M | 30.51M | 20.66M | 19.70M | 17.02M | 15.89M | 13.17M | 9.36M | 8.60M | 8.58M | 8.12M | 8.32M | 7.43M | 8.01M | 8.31M | 5.95M | 5.55M | 5.51M | 2.61M | 347.00K |
| Interest Income | 402.00K | 657.00K | 471.00K | 71.00K | 336.00K | 377.00K | 139.00K | 4.00K | 2.00K | 76.00K | 134.00K | 41.00K | 172.00K | 122.00K | 9.00K | 14.00K | 27.00K | 33.00K | 18.00K | 38.00K | 44.00K | 0.00 |
| Interest Expense | 86.00K | 95.00K | 103.00K | 121.00K | 114.00K | 71.00K | 140.00K | 7.00K | 24.00K | 58.00K | 156.00K | 0.00 | 0.00 | 0.00 | 1.00K | 13.00K | 6.00K | 100.00K | 169.00K | 176.00K | 124.00K | 0.00 |
| Depreciation & Amortization | 3.39M | 3.11M | 2.95M | 3.75M | 2.60M | 2.27M | 1.78M | 1.33M | 1.10M | 274.00K | 259.00K | 231.00K | 247.00K | 367.00K | 352.00K | 357.00K | 318.00K | 248.00K | 244.00K | 596.00K | 326.00K | 347.00K |
| EBITDA | -29.45M | -4.28M | -12.86M | -11.11M | 3.03M | 3.89M | 2.22M | 3.80M | 3.42M | 2.63M | 959.00K | 4.01M | 3.44M | 2.25M | 1.63M | 1.55M | 1.63M | 2.05M | 1.57M | 1.13M | 1.14M | 5.48M |
| EBITDA Ratio | -88.83% | -53.07% | -58.11% | -5.90% | 19.84% | 20.89% | 16.41% | 21.72% | 25.49% | 27.62% | 21.01% | 34.17% | 30.37% | 22.05% | 19.60% | 17.70% | 17.63% | 27.73% | 23.80% | 20.91% | 37.34% | 100.00% |
| Operating Income | -16.87M | -20.27M | -15.70M | -5.24M | 1.87M | 3.17M | 2.07M | 3.50M | 3.56M | 2.93M | 1.71M | 3.78M | 3.19M | 1.88M | 863.00K | 717.00K | 912.00K | 1.52M | 1.06M | -107.00K | 438.00K | 5.13M |
| Operating Income Ratio | -50.88% | -62.69% | -71.53% | -20.73% | 8.31% | 15.20% | 11.85% | 19.08% | 22.98% | 25.26% | 18.25% | 32.20% | 28.19% | 18.45% | 10.40% | 8.22% | 9.89% | 20.48% | 16.03% | -1.98% | 14.37% | 93.66% |
| Total Other Income/Expenses | -16.06M | 12.95M | -213.00K | -9.74M | -1.55M | -1.62M | -1.77M | -1.04M | -1.26M | -756.00K | -1.07M | -586.00K | 600.00K | 612.00K | 410.00K | 101.00K | 389.00K | 188.00K | 100.00K | 465.00K | 250.00K | -3.13M |
| Income Before Tax | -32.93M | -7.49M | -15.91M | -14.98M | 321.00K | 1.55M | 301.00K | 2.46M | 2.30M | 2.18M | 641.00K | 3.19M | 3.79M | 2.50M | 1.27M | 1.18M | 1.30M | 1.70M | 1.16M | 358.00K | 688.00K | 2.00M |
| Income Before Tax Ratio | -99.33% | -23.17% | -72.50% | -59.27% | 1.42% | 7.43% | 1.72% | 13.42% | 14.87% | 18.75% | 6.84% | 27.21% | 33.49% | 24.45% | 15.34% | 13.46% | 14.11% | 23.03% | 17.55% | 6.62% | 22.57% | 36.44% |
| Income Tax Expense | 8.07M | -1.88M | -3.50M | -2.41M | -58.00K | 513.00K | 58.00K | 643.00K | 732.00K | 647.00K | 234.00K | 883.00K | 1.09M | 752.00K | 394.00K | 365.00K | 410.00K | 496.00K | 362.00K | 358.00K | 688.00K | 2.00M |
| Net Income | -40.99M | -5.61M | -12.41M | -12.57M | 379.00K | 1.04M | 243.00K | 1.82M | 1.57M | 1.53M | 875.00K | 2.31M | 2.70M | 1.74M | 879.00K | 810.00K | 891.00K | 1.21M | 797.00K | 168.00K | 481.00K | 0.00 |
| Net Income Ratio | -123.66% | -17.35% | -56.54% | -49.72% | 1.68% | 4.97% | 1.39% | 9.92% | 10.14% | 13.17% | 9.34% | 19.68% | 23.90% | 17.08% | 10.60% | 9.28% | 9.66% | 16.32% | 12.07% | 3.11% | 15.78% | 0.00% |
| EPS | -0.46 | -0.07 | -0.17 | -0.18 | 0.01 | 0.02 | 0.00 | 0.03 | 0.03 | 0.03 | 0.02 | 0.04 | 0.05 | 0.03 | 0.02 | 0.01 | 0.02 | 0.02 | 0.01 | 0.00 | 0.01 | 0.00 |
| EPS Diluted | -0.46 | -0.07 | -0.17 | -0.18 | 0.01 | 0.02 | 0.00 | 0.03 | 0.03 | 0.03 | 0.02 | 0.04 | 0.05 | 0.03 | 0.02 | 0.01 | 0.02 | 0.02 | 0.01 | 0.00 | 0.01 | 0.00 |
| Weighted Avg Shares Out | 88.60M | 84.27M | 72.43M | 69.57M | 66.64M | 65.66M | 59.08M | 58.71M | 58.11M | 58.66M | 57.64M | 56.64M | 54.29M | 52.19M | 52.19M | 55.49M | 57.73M | 57.90M | 57.90M | 57.90M | 46.15M | 57.90M |
| Weighted Avg Shares Out (Dil) | 88.60M | 84.27M | 72.43M | 69.57M | 66.97M | 66.01M | 59.08M | 58.71M | 58.14M | 58.81M | 57.64M | 56.64M | 54.29M | 52.19M | 52.19M | 55.49M | 57.73M | 57.90M | 57.90M | 57.90M | 46.15M | 57.90M |
Source: https://incomestatements.info
Category: Stock Reports